BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26562475)

  • 1. Oct4 is a reliable marker of liver tumor propagating cells in hepatocellular carcinoma.
    Wu G; Wilson G; Zhou G; Hebbard L; George J; Qiao L
    Discov Med; 2015 Oct; 20(110):219-29. PubMed ID: 26562475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
    Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
    Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma.
    Tovar V; Cornella H; Moeini A; Vidal S; Hoshida Y; Sia D; Peix J; Cabellos L; Alsinet C; Torrecilla S; Martinez-Quetglas I; Lozano JJ; Desbois-Mouthon C; Solé M; Domingo-Domenech J; Villanueva A; Llovet JM
    Gut; 2017 Mar; 66(3):530-540. PubMed ID: 26658144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
    Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
    Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
    Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets.
    Murakami S; Ninomiya W; Sakamoto E; Shibata T; Akiyama H; Tashiro F
    Stem Cells; 2015 Sep; 33(9):2652-63. PubMed ID: 26013162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.
    Kwon YC; Bose SK; Steele R; Meyer K; Di Bisceglie AM; Ray RB; Ray R
    J Virol; 2015 Nov; 89(22):11549-56. PubMed ID: 26355082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krüppel-like factor 8 promotes cancer stem cell-like traits in hepatocellular carcinoma through Wnt/β-catenin signaling.
    Shen YN; He HG; Shi Y; Cao J; Yuan JY; Wang ZC; Shi CF; Zhu N; Wei YP; Liu F; Huang JL; Yang GS; Lu JH
    Mol Carcinog; 2017 Feb; 56(2):751-760. PubMed ID: 27478926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells.
    Wilson GS; Hu Z; Duan W; Tian A; Wang XM; McLeod D; Lam V; George J; Qiao L
    Stem Cells Dev; 2013 Oct; 22(19):2655-64. PubMed ID: 23638793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection.
    Zhao RC; Zhou J; Chen KF; Gong J; Liu J; He JY; Guan P; Li B; Qin Y
    Neoplasma; 2016; 63(2):288-98. PubMed ID: 26674131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.
    Qian YW; Chen Y; Yang W; Fu J; Cao J; Ren YB; Zhu JJ; Su B; Luo T; Zhao XF; Dai RY; Li JJ; Sun W; Wu MC; Feng GS; Wang HY
    Gastroenterology; 2012 Jun; 142(7):1547-58.e14. PubMed ID: 22387393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
    Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
    PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells.
    Zhu P; Wang Y; He L; Huang G; Du Y; Zhang G; Yan X; Xia P; Ye B; Wang S; Hao L; Wu J; Fan Z
    J Clin Invest; 2015 Oct; 125(10):3795-808. PubMed ID: 26426078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
    Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
    Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
    Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
    Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenite inhibits the function of CD133
    Tang H; Jin Y; Jin S; Tan Z; Peng Z; Kuang Y
    Tumour Biol; 2016 Oct; 37(10):14103-14115. PubMed ID: 27517564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness.
    Bi L; Ren Y; Feng M; Meng P; Wang Q; Chen W; Jiao Q; Wang Y; Du L; Zhou F; Jiang Y; Chen F; Wang C; Tang B; Wang Y
    Cancer Res; 2021 Apr; 81(8):2015-2028. PubMed ID: 33602787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer.
    Gao DY; Lin TsT; Sung YC; Liu YC; Chiang WH; Chang CC; Liu JY; Chen Y
    Biomaterials; 2015 Oct; 67():194-203. PubMed ID: 26218745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4.
    Jiang Z; Zhang C; Liu X; Ma X; Bian X; Xiao X; Gao R; Sun Y; Wu W; Zhao P
    Int J Oncol; 2020 Sep; 57(3):780-790. PubMed ID: 32705164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.